Top Markets
#1 Black Phoenix Black Phoenix +21,406.19%
#2 Nesa Nesa +679.66%
#3 Cortex Cortex +92.45%
#4 Ontology Gas Ontology Gas +59.74%
#5 Kinesis Silver Kinesis Silver +53.75%
#6 Biconomy Biconomy +26.93%
#7 Magma Finance Magma Finance +24.36%
#8 QuantixAI QuantixAI +23.07%
#9 EXOD EXOD +22.78%
#10 SAFEcoin SAFEcoin +20.40%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Veradermics, Incorporated Veradermics, Incorporated

Veradermics, Incorporated

MANE
Classifica tra le azioni #3972
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused... Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
Prezzo delle azioni
$104.17
Capitalizzazione di mercato
$4.35B
Variazione (1 giorno)
1.76%
Variazione (1 anno)
-
Paese
US
Scambia Veradermics, Incorporated (MANE)

Categoria

Healthcare
Ricavi di Veradermics, Incorporated (MANE)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Veradermics, Incorporated, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Veradermics, Incorporated da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH